Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stempeucel in Ischemic Cerebral Stroke
NCT01091701Phase 2Withdrawn
- Sponsor
- Stempeutics Research
- Start
- Dec 2011
- Primary completion
- May 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Stempeucel in ischemic stroke, sponsored by Stempeutics Research. Planned start Dec 2011; status: withdrawn.
02
Drugs
Stempeucel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01091701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091701.